Drug Discovery Market Forecast Showing Industry Progress And Growth Trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Drug Discovery Market Be By 2030 Compared To Its 2026 Market Size?

The drug discovery market size has expanded considerably in recent years. It is anticipated to grow from $124.11 billion in 2025 to $142.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.8%. The increase observed in the past can be attributed to several factors, including a rise in chronic and infectious diseases, advancements in molecular biology techniques, increased R&D spending by pharmaceutical companies, growth in biotechnology collaborations, and the availability of research funding.

The drug discovery market is expected to witness significant expansion in the foreseeable future, with its size projected to reach $250.51 billion by 2030, reflecting a compound annual growth rate (CAGR) of 15.1%. This growth during the forecast period can be attributed to factors such as the rise of AI-driven drug discovery platforms, the increasing adoption of personalized medicine, the integration of omics data in drug design, the growth in biopharmaceutical outsourcing, and the widespread use of automation and robotics in laboratories. Key trends anticipated during this period include advancements in high-throughput screening, the development of targeted drugs, the expansion of personalized medicine approaches, the integration of pharmacogenomics, and the application of nanotechnology in drug discovery.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Significant Factors Are Influencing The Drug Discovery Market Expansion?

The drug discovery market is anticipated to expand due to increasing healthcare expenditure. Globally, nations allocate a substantial portion of their GDP to healthcare costs, encompassing areas such as hospital care, physician and clinical services, other professional services, dental services, other health, residential, and personal care, home health care, nursing care facilities, and continuing care retirement communities, alongside prescription drugs, among others. Drug discovery constitutes a considerable component of this health spending, given its necessity for treating illnesses and extending lifespan. There is a growing demand for novel drugs to address emerging diseases. For example, reports from October 2024 by the Centers for Medicare and Medicaid Services, a US federal agency, indicated that national health expenditure expanded by 4.1% to $4.5 trillion in 2022, amounting to $13,493 per person. Furthermore, from 2023–32, the average national health expenditure growth (5.6%) is projected to exceed the average GDP growth (4.3%), leading to an increase in health spending’s share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, the escalation in healthcare expenditures is fueling the expansion of the drug discovery market.

How Is The Drug Discovery Market Broken Down By Segment Categories?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

What Emerging Trends Are Seen In The Drug Discovery Market?

Leading companies in the drug discovery market are implementing various new technologies, such as AI, imaging technology, and other innovations, to decrease the time required for drug discovery. Imaging technology allows for the visualization, characterization, and quantification of non-invasive biological activities occurring within organisms in response to medications. These techniques, which utilize the strengths of either specific probes or the tissue itself, are essential for understanding diseases and discovering new treatments. For example, in May 2023, Google Cloud recently introduced two new AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, to accelerate advancements in drug discovery and precision medicine. These tools are developed to support biotech and pharmaceutical companies in their progress within drug discovery and personalized medicine. The Target and Lead Identification Suite helps in pinpointing the function of amino acids and proteins, while the Multiomics Suite expedites the discovery and interpretation of genomic data, thereby assisting in the formulation of precision treatments.

Which Players Are Present In The Drug Discovery Market Space?

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Get The Full Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Region Has The Greatest Market Share In The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug Discovery Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Browse Through More Reports Similar to the Global Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795